Skip to main content

Table 5 The risk factors for chemotherapy-associated lymphopenia <0.91 × 10 9 /L in colorectal cancer by multivariate logistic regression model

From: The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer

Variables

Odds ratio

95% confidence intervals

P-value

Pretreatment albumin

   

≥35 g/L

1.00(ref.)

  

<35 g/L

1.410

0.772-2.576

0.263

Pretreatment CEA a

   

<10 ng ml-1

1.00(ref.)

  

≥10 ng ml-1

1.885

0.984-3.610

0.056

Differentiation

   

Well

1.00(ref.)

  

Moderately

1.590

0.564-4.483

0.381

Low

2.694

0.694-10.458

0.152

Sex

   

Male

1.00(ref.)

  

Female

1.725

0.987-3.016

0.056

Age

   

≤49 years

1.00(ref.)

  

50-60 yeas

1.617

0.705-3.709

0.256

>60 years

2.872

1.344-6.136

0.006

Location

   

Rectum

1.00(ref.)

  

Left colon cancer

0.948

0.502-1.789

0.869

Right colon cancer

0.780

0.381-1.596

0.496

Stage

   

II

1.00(ref.)

  

III

0.881

0.494-1.572

0.668

  1. a Carcinoembryonic antigen.